Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (560kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-598109
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.59810
Zusammenfassung
Background: Cefiderocol may potentially be used to treat skin and soft tissue infections (SSTIs). However, the pharmacokinetics of cefiderocol in human soft tissues have not yet been determined. The objective of the present PK study was to investigate whether target-site concentrations of cefiderocol are sufficiently high for the treatment of SSTIs. Methods: In this pharmacokinetic study, a ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags